Aemetis (AMTX) Lowered to “Sell” at Zacks Investment Research

Aemetis (NASDAQ:AMTX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, B. Riley restated a “neutral” rating on shares of Aemetis in a research note on Wednesday, November 1st.

Aemetis (NASDAQ AMTX) opened at $0.52 on Tuesday. The company has a market capitalization of $10.70, a PE ratio of -0.51 and a beta of 1.00. Aemetis has a one year low of $0.45 and a one year high of $1.81. The company has a debt-to-equity ratio of -1.87, a quick ratio of 0.20 and a current ratio of 0.37.

An institutional investor recently bought a new position in Aemetis stock. Atlantic Trust Group LLC purchased a new position in Aemetis Inc (NASDAQ:AMTX) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,468,507 shares of the specialty chemicals company’s stock, valued at approximately $1,278,000. Atlantic Trust Group LLC owned approximately 7.41% of Aemetis as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 17.73% of the company’s stock.

WARNING: This report was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2018/02/15/aemetis-amtx-lowered-to-sell-at-zacks-investment-research.html.

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply